Ventum Financial Downgrades Sylogist (TSE:SYZ) to Neutral

Sylogist (TSE:SYZGet Free Report) was downgraded by equities researchers at Ventum Financial from a “buy” rating to a “neutral” rating in a report released on Friday,BayStreet.CA reports. They presently have a C$4.75 price target on the stock, down from their prior price target of C$7.00. Ventum Financial’s target price points to a potential upside of 25.00% from the company’s previous close.

Separately, Stifel Nicolaus lowered shares of Sylogist from a “buy” rating to a “hold” rating and cut their target price for the company from C$9.00 to C$4.75 in a report on Thursday, February 12th. Two investment analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of C$4.75.

Read Our Latest Stock Analysis on SYZ

Sylogist Price Performance

Shares of Sylogist stock opened at C$3.80 on Friday. The firm has a market cap of C$88.88 million, a PE ratio of -29.69 and a beta of 0.20. The stock has a 50 day moving average of C$4.30 and a 200 day moving average of C$5.47. The company has a current ratio of 0.82, a quick ratio of 0.51 and a debt-to-equity ratio of 61.28. Sylogist has a 12 month low of C$3.03 and a 12 month high of C$9.99.

Sylogist Company Profile

(Get Free Report)

Sylogist is a public sector SaaS company that provides comprehensive ERP, CRM, fundraising, education administration, and payments solutions that allow its customers to carry out their missions.It serves over 2,000 customers globally, including all levels of government, nonprofit and non-governmental organizations, educational institutions, and public compliance-driven and funded companies. Sylogist has industry-leading profitability, an exceptionally strong balance sheet, a track record of successful acquisitions, and a portfolio of mission-critical SaaS solutions.

Further Reading

Receive News & Ratings for Sylogist Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sylogist and related companies with MarketBeat.com's FREE daily email newsletter.